Prosight Management’s Pacira BioSciences PCRX Stock Holding History

Prosight Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$2.76M	Sell
2023 Q4	$8.72M	Sell
2023 Q3	$37.1M	Buy
2023 Q2	$35.2M	Buy
2023 Q1	$3.72M	Buy
2020 Q3	–	Sell
2020 Q2	$2.89M	Buy